This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Roberts, W. N. Articles by Carr, M. E. Search for Related Content PubMed PubMed Citation Articles by Roberts, W. N. Articles by Carr, M. E. Social Bookmarking                         What's this?

Comparison of Factor VIII-Related Antigen and Erythrocyte Sedimentation Rate in Outpatient Management of Vasculitis

Divisions of Rheumatology, Allergy & Immunology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia.

James P. Brodeur, M.D.

Divisions of Rheumatology, Allergy & Immunology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia.

John DeWitt, M.D.

Divisions of Rheumatology, Allergy & Immunology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia.

Sheryl Z. Carr, B.S.

Hematology/Oncology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia.

Christopher M. Wise, M.D.

Divisions of Rheumatology, Allergy & Immunology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia.

Marcus E. Carr, M.D., Ph.D.

Hematology/Oncology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia.

Electroimmunodiffusion (Laurell rocket) determinations of factor VIII-related antigen in plasma were ordered to determine the cost/benefit ratio for factor VIII-related antigen as a putative test for endothelial damage in suspected vasculitis.

Twenty-seven consecutive patients referred for vasculitis or suspected vasculitis were identified and followed up for an average of 9.1 ±months (range: one to thirty-three months) in a prospective, unblinded study performed in a clinic, associated with a 1054- bed inner-city university hospital. There was no difference in Westergren erythrocyte sedimentation rate (WESR) in patients with final diagnosis of systemic vasculitis (SV) (38 ± 12 mm/hour) compared to those without vasculitis (NV) (27 ± 7) as the final diagnosis. The mean plasma concentration of factor VIII-related antigen was significantly elevated in SV (344 ±100%) when compared with NV (147 ±39%) (P < 0.016). The factor VIII- related antigen test in this study was 2.56 times more likely (crude odds ratio) than the WESR to contribute to a change in diagnosis or therapy (P=0.016). Positive and negative predictive values (PPV and NPV) for factor VIII-related antigen (abnormal at greater than 220% of the normal value) were both 70%. PPV and NPV for WESR were 56% and 86%, respectively.

The factor VIII-related test was less cost-effective than the WESR in the follow-up period unless it was important to define complete remission or differentiate vasculitis flare from infection. The authors conclude that factor VIII-related antigen is a useful test in the initial diagnosis of vasculitis.

Angiology, Vol. 47, No. 11, 1081-1087 (1996)
DOI: 10.1177/000331979604701108


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?